Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-003520
Filing Date
2015-05-12
Accepted
2015-05-12 16:06:32
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0315_immucellcorp.htm 10-Q 472762
2 AMENDMENT TO RIGHTS AGREEMENT f10q0315ex4i_immucellcorp.htm EX-4.1 18401
3 CERTIFICATION f10q0315ex31_immucellcorp.htm EX-31 8985
4 CERTIFICATION f10q0315ex32_immucellcorp.htm EX-32 5557
5 GRAPHIC img_001.jpg GRAPHIC 108831
6 GRAPHIC img_002.jpg GRAPHIC 85500
  Complete submission text file 0001213900-15-003520.txt   4267430

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE iccc-20150331.xml EX-101.INS 444920
8 XBRL SCHEMA FILE iccc-20150331.xsd EX-101.SCH 36991
9 XBRL CALCULATION FILE iccc-20150331_cal.xml EX-101.CAL 64000
10 XBRL DEFINITION FILE iccc-20150331_def.xml EX-101.DEF 73759
11 XBRL LABEL FILE iccc-20150331_lab.xml EX-101.LAB 326175
12 XBRL PRESENTATION FILE iccc-20150331_pre.xml EX-101.PRE 217800
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 15854493
SIC: 2835 In Vitro & In Vivo Diagnostic Substances